News & Perspective

Dec 21, 2001

Dec 21, 2001

FDA completes inspection of anthrax vaccine plant; company expects approval

(CIDRAP News) – The Food and Drug Administration (FDA) has completed a new inspection of BioPort Corp., the only US manufacturer of the anthrax vaccine, and a company official is predicting approval of the facility after a few remaining concerns are ironed out.

Dec 19, 2001

Dec 19, 2001

Anthrax vaccine to be offered to postal and Capitol workers

(CIDRAP News) – Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.

Dec 13, 2001

Dec 13, 2001

House passes $2.9 billion authorization for bioterrorism preparedness

(CIDRAP News) – The US House of Representatives on Wednesday overwhelmingly approved a bill authorizing about $2.9 billion in spending on preparedness for bioterrorism and other public health emergencies.

Nov 30, 2001

Nov 30, 2001

Acambis wins new contract to supply 155 million doses of smallpox vaccine

Nov 29, 2001 (CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded Acambis Inc. a $428 million contract to produce an additional 155 million doses of smallpox vaccine by the end of 2002, HHS Secretary Tommy G. Thompson announced Wednesday.